Neurological diseases are caused by complex interactions between many genes. Many drug discoveries fail because researchers target only one gene at a time. Using the same breakthroughs that power Google’s search engines, we’ve discovered a way to map out the hundreds of genes that cause a disease, and then find drugs that target all the genes at once.
Neurological diseases, such as Alzheimer's disease, Parkinson's Disease, and amyotrophic lateral sclerosis (ALS) result in suffering, disability, and death for millions of Americans, and cause more than a trillion dollars in economic damage. There are no effective, disease-modifying treatments for these diseases. In the past, most neuroscientists did not have the tools to disentangle the complex genetics of these diseases. Our platform is specifically designed for neurodegenerative disease, and can analyze thousands of datasets to predict which drugs will work. Verge's genomic network approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally bend the cost curve of pharmaceutical development.
San Francisco, January 8, 2016
TechCrunch, November 3, 2015
BioWorld Today, October 29, 2015
San Francisco, October 28, 2015